Abstract |
The potential promotion activity on nasal carcinogenesis of 2,6-dimethylaniline (DMA), an alpha2-adrenergic agonist metabolite of xylazine which is used for food-producing animals as a sedative agent, was examined. Male F344 rats received diet containing 0 or 3000 ppm DMA for 52 weeks after initiation with N-bis(2-hydroxypropyl)nitrosamine ( DHPN). Histopathological assessment showed the incidence of carcinomas in the DHPN+DMA group (33%) to be significantly elevated as compared with that for the DHPN-alone group (5%). Incidences and/or multiplicity of epithelial hyperplasias and dysplastic foci were also increased in the DHPN+DMA group. These lesions were exclusively observed in the olfactory mucosa. The lowest plasma levels of DMA in tumor- and dysplastic foci-bearing rats were 0.05 and 0.20 microg/ml, respectively. These results indicate that DHPN acts as an appropriate initiator for nasal carcinogenesis and that DMA exerts a tumor-promoting effect on the olfactory mucosa in the rat nasal cavity.
|
Authors | T Koujitani, K Yasuhara, H Kobayashi, A Shimada, H Onodera, H Takagi, M Hirose, K Mitsumori |
Journal | Cancer letters
(Cancer Lett)
Vol. 142
Issue 2
Pg. 161-71
(Aug 03 1999)
ISSN: 0304-3835 [Print] Ireland |
PMID | 10463772
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic alpha-Agonists
- Aniline Compounds
- Carcinogens
- Nitrosamines
- 2,6-xylidine
- diisopropanolnitrosamine
|
Topics |
- Adenoma
(blood, chemically induced, pathology)
- Adrenergic alpha-Agonists
(pharmacology)
- Aniline Compounds
(blood, pharmacology)
- Animals
- Carcinogens
(pharmacology, toxicity)
- Carcinoma
(blood, chemically induced, pathology)
- Drug Synergism
- Male
- Nasal Mucosa
(drug effects, pathology)
- Nitrosamines
(toxicity)
- Nose Neoplasms
(blood, chemically induced, pathology)
- Rats
- Rats, Inbred F344
- Turbinates
(drug effects, pathology)
|